Sign Up Today and Learn More About Ganymede Stock
Invest in or calculate the value of your shares in Ganymede or other pre-IPO companies through EquityZen's platform.
Ganymede Stock (GANY)
Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.
About Ganymede Stock
Founded
2022
Headquarters
Palo Alto, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ganymede Press Mentions
Stay in the know about the latest news on Ganymede
Ganymede Bio Launches Industry-First GxP-Native Developer Platform and Data Infrastructure for Wet Lab Data
businesswire • Sep 03, 2024
Ganymede's rebranded Dark Sky video game nears launch
bizjournals • Mar 12, 2024
New patent, Ganymede Technologies grant, UH report ...
mansfieldnewsjournal • Dec 23, 2023
Ganymede Technologies grant, Crestline library programs, tip ...
bucyrustelegraphforum • Dec 23, 2023
SciNote Electronic Lab Notebook (ELN) and Ganymede Bio Partner to Streamline Instrument Integration and Scientific Data Reporting
prnewswire • Dec 02, 2023
Ganymede Management
Leadership team at Ganymede
Co-Founder
Benson Lee
Board Member
Varun Gupta
Join now and verify your accreditation status to gain access to:
- Ganymede current valuation
- Ganymede stock price
- Available deals in Ganymede and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Ganymede stock?
Accredited investors can buy pre-IPO stock in companies like Ganymede through EquityZen funds. These investments are made available by existing Ganymede shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ganymede stock?
Shareholders can sell their Ganymede stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
